These benefits, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assist the thought of focusing on ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. Based on available science https://menachemw961jqw5.shopping-wiki.com/user